There is a lot of buzz about “the cloud.” Formally known as cloud computing, the cloud relies on sharing of Information Technology (IT) resources.
Three key insights about clinical trial advancements made possible by the advent of metrics
The concept of the human challenge model (HCM) originated from early societal attempts to halt the spread of acute diseases within their own communities
How optimizing RBQM risk detection reduces the efforts caused by false signals.
In clinical trials, the ability to effectively plan, collect and maintain essential clinical trial documentation is challenging.
EDC has become the data management platform of choice around the world, offering advantages such as increasing the quality and timely collection of data. Medrio, an EDC company that offers eClinical software solutions, has quoted that 70% of clinical trials are using EDC as a forms of collecting data in the United States. In China, we have seen adoption rates for EDC increase dramatically in recent years, fuelled by improved technology developments in mobile applications, and the increasing experience with EDC usage in clinical research.
The importance of examining this generation’s influence on the clinical trial value chain.
In this analysis, distinctions between who hires who in non-Chinese and China-based companies emerges.
With all the buzz around wearables, actigraphs-which monitor sleep and daytime activity levels-have been around for decades.
In this analysis, distinctions between who hires who in non-Chinese and China-based companies emerges.
A survey from the Avoca Group examines issues related to quality of clinical trials and trial participation from the patients' view.
While the fundamental concerns behind the design of most modern clinical trials are effectively the same, clinical trials that take place during public health emergencies face additional layers of challenges.
Over the past three decades, clinical imaging has become an integral part of the drug development process for biopharmaceutical companies.
Liz Rogers, VP and Head of Global Site and Study Operations at Pfizer, discusses Pfizer's partnership with Parexel and transition to a functional service provider (FSP) model.
Demand for outsourced services to provide clinical development capacity and expertise has grown substantially over the last 10 years.
Demand for outsourced services to provide clinical development capacity and expertise has grown substantially over the last 10 years.
Promising new approaches to optimize data and outcomes.
Cenduit has benefited greatly from the relationship we have with our parent companies, from Quintiles’ clinical development experience to Thermo Fisher Scientific’s clinical supply chain know-how.
Examining the practical significance of reporting patient deaths due to main disease progression.
Examining the practical significance of reporting patient deaths due to main disease progression.
Study measures the differing judgment levels between clinical investigators and drug safety experts.
Examining the practical significance of reporting patient deaths due to main disease progression.
Two unique techniques help characterize pharmacodynamic drug effects in healthy subjects.
Knowledge is power, but power is of no value if you don't exercise it.
This experimental technique is being studied to see whether it could treat certain health problems.
This experimental technique is being studied to see whether it could treat certain health problems.